Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a randomized, multicenter phase II study of pembrolizumab in combination with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma to examine the safety and efficacy of the combination of pembrolizumab with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma as assessed by 1 year disease free survival rate.
Epistemonikos ID: b1631f06985c66f096f0f27f70c6c91d7285945b
First added on: May 20, 2024